SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in market interest, driven by speculation over potential partnerships with major hyperscalers and its critical role in AI optical interconnects. The community is actively discussing the stock's parabolic volume and momentum, with longs celebrating the potential for a sustained breakout while shorts remain under intense pressure.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is experiencing significant volatility and downward pressure as shareholders react to a recent shelf offering and concerns over clinical trial timelines. While the community remains polarized, with some investors accumulating shares on dips anticipating future trial data and a potential short squeeze, others are expressing frustration over the persistent selling and lack of clear upward momentum.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging alongside other semiconductor leaders as strong CPU performance data from Intel drives sector-wide momentum and investor FOMO. The community is actively debating whether this parabolic rally is a sustainable AI-driven breakout or an overextended bubble, with many traders focused on short squeezes and aggressive price action.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as retail investors react to a recent convertible notes offering, which triggered short-term volatility despite analysts viewing it as a move to strengthen the company's balance sheet for long-term R&D. The community remains deeply divided, with many long-term holders expressing frustration over price stagnation and leadership execution, while others highlight the company's $2 billion cash pile and upcoming clinical data catalysts as reasons to remain bullish.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) has captured significant community attention due to its historic streak of consecutive green sessions and parabolic price action, prompting intense debate over whether it represents a sustainable AI-driven bull run or an overdue blow-off top. Investors are actively discussing the risks of extreme overbought conditions while weighing tactical hedging strategies, such as using inverse ETFs, against a bullish narrative centered on unrelenting demand for AI infrastructure.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm shares are facing downward pressure as investors weigh strong automotive and IoT revenue against a cautious second-quarter outlook fueled by global memory chip supply constraints. The community is currently debating whether the current price represents an attractive value opportunity given the stock's low P/E ratio or if persistent handset market headwinds suggest further downside.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing intense volatility and record-breaking momentum, with community debate centered on whether this surge represents a sustainable AI-driven growth cycle or a speculative bubble reminiscent of the dot-com era. Traders are actively discussing the extreme technical overextension and concentration of the trade, with many weighing the risks of a blow-off top against the potential for continued upside from data center demand.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as traders aggressively reprice the stock following a significant earnings beat and raised guidance that highlights its growing role in AI-driven data center infrastructure. The community remains divided, with bulls pointing to fundamental momentum and institutional interest, while bears warn of a potential overvaluation and pump-and-dump mechanics after the recent parabolic price move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RiverNorth Opportunities Fund, Inc. and RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Announce Preferred Dividends

RiverNorth Opportunities Fund, Inc. and RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. are each pleased to announce the declaration of preferred dividends for the second quarter of 2026, as...

RiverNorth Closed-End Funds Declare Monthly Distributions

In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the Funds have established the distribution dates for April, May, and June 2026. The payments of the...

In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the reset distribution rates have been proposed for the calendar year 2026, as detailed below. Further, the...

RiverNorth Opportunities Fund, Inc. Announces Final Results of Rights Offering

RiverNorth Opportunities Fund, Inc. (the Fund) (NYSE: RIV) today announced the final results of its transferable rights offering (the Offering). The Fund will issue a total of 5,899,015 new shares of...

RiverNorth Opportunities Fund, Inc. is a closed-end management investment company. Its investment objective is total return consisting of capital appreciation and current income. Its activities include investment in other underlying funds not classified as closed-end funds and exchange-traded notes and cash and cash equivalents; and securities lending. The company was founded on September 9, 2010 and is headquartered in West Palm Beach, FL.

RIV
RiverNorth Opportunities Fund Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest RIV News

RIVRiverNorth Opportunities Fund Inc